Lv3
210 积分 2023-11-08 加入
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
2天前
已完结
Milestones in tumor vascularization and its therapeutic targeting
5个月前
已完结
Why do patients with cancer die?
6个月前
已完结
Exploring the next generation of antibody–drug conjugates
9个月前
已完结
Advances in antibody-based therapy in oncology
1年前
已完结
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
1年前
已完结
皖公网安备34019202002308
